Managers / Q2 2023 · view latest →
Cahill Wealth Management, LLC
CIK 0001927960 · 5831 OAKLAND DRIVE, PORTAGE, MI, 49024 · 269-321-6600
Summary
Cahill Wealth Management, LLC reported $145M in U.S.-listed holdings across 47 positions for Q2 2023.
The portfolio is heavily concentrated: IVV alone accounts for 51.0% of reported value.
The book was largely unchanged from Q1 2023.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 84.4% · $122M
- Common Stock · 15.3% · $22M
- ADR · 0.2% · $254,632
- Other · 0.1% · $216,702
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| EXPION360 INC | ADDED | +15.8K | 43.6K | +$82,285 | $216,702 |
| MRNAMODERNA INC | TRIMMED | −1.1K | 2.0K | −$228,443 | $246,888 |
| DFAIDIMENSIONAL ETF TRUST | ADDED | +7.6K | 55.5K | +$226,564 | $2M |
| CLPTCLEARPOINT NEURO INC | ADDED | +21.6K | 185.5K | −$40,224 | $1M |
| SRTSSENSUS HEALTHCARE INC | ADDED | +8.3K | 73.9K | −$108,860 | $232,656 |
| AGGISHARES TR | ADDED | +2.9K | 27.6K | +$246,594 | $3M |
| PRFINVESCO EXCHANGE TRADED FD T | TRIMMED | −718 | 10.5K | −$40,211 | $2M |
| DFEMDIMENSIONAL ETF TRUST | ADDED | +2.3K | 42.1K | +$73,886 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVVISHARES TR | CORE S&P500 ETF · CORE S&P SCP ETF · CORE S&P MCP ETF · CORE US AGGBD ET · 20 YR TR BD ETF · EAFE SML CP ETF · RUS 1000 GRW ETF · RUS MD CP GR ETF · RUSSELL 2000 ETF | 50.99% | $74M | 280.9K |
| 2 | DFACDIMENSIONAL ETF TRUST | US CORE EQUITY 2 · US SMALL CAP VAL · INTL CORE EQUITY · INTL CORE EQT MK · EMGR CRE EQT MNG · EMERGING MKTS CO · US SMALL CAP ETF · US CORE EQT MKT · INTL SMALL CAP E | 14.65% | $21M | 797.4K |
| 3 | BRK/ABERKSHIRE HATHAWAY INC DEL | CL A · CL B NEW | 8.02% | $12M | 689 |
| 4 | VTIVANGUARD INDEX FDS | TOTAL STK MKT · SMALL CP ETF · MCAP GR IDXVIP · S&P 500 ETF SHS · SM CP VAL ETF | 7.39% | $11M | 48.9K |
| 5 | BNDVANGUARD BD INDEX FDS | TOTAL BND MRKT · INTERMED TERM | 5.21% | $8M | 102.9K |
| 6 | AAPLAPPLE INChistory → | COM | 2.49% | $4M | 18.6K |
| 7 | SPYSPDR S&P 500 ETF TRhistory → | TR UNIT | 1.90% | $3M | 6.2K |
| 8 | XPELXPEL INChistory → | COM | 1.53% | $2M | 26.3K |
| 9 | PRFINVESCO EXCHANGE TRADED FD Thistory → | FTSE RAFI 1000 | 1.19% | $2M | 10.5K |
| 10 | SYKSTRYKER CORPORATION | COM | 0.96% | $1M | 4.6K |
| 11 | CLPTCLEARPOINT NEURO INC | COM | 0.93% | $1M | 185.5K |
| 12 | SPDR SER TR | PORTFOLI S&P1500 | 0.89% | $1M | 23.7K |
| 13 | SCHBSCHWAB STRATEGIC TR | US BRD MKT ETF | 0.61% | $881,933 | 17.1K |
| 14 | MAMASTERCARD INCORPORATED | CL A | 0.56% | $810,592 | 2.1K |
| 15 | VEAVANGUARD TAX-MANAGED FDS | VAN FTSE DEV MKT | 0.54% | $778,043 | 16.8K |
| 16 | VEUVANGUARD INTL EQUITY INDEX F | ALLWRLD EX US · FTSE EMR MKT ETF | 0.53% | $770,215 | 15.5K |
| 17 | VCSHVANGUARD SCOTTSDALE FDS | SHRT TRM CORP BD · LG-TERM COR BD | 0.47% | $679,253 | 8.9K |
| 18 | AMZNAMAZON COM INC | COM | 0.31% | $443,144 | 3.4K |
| 19 | VRNAVERONA PHARMA PLC | SPONSORED ADS | 0.18% | $254,632 | 12.0K |
| 20 | ZTSZOETIS INC | CL A | 0.17% | $249,308 | 1.4K |
| 21 | MRNAMODERNA INC | COM | 0.17% | $246,888 | 2.0K |
| 22 | SRTSSENSUS HEALTHCARE INC | COM | 0.16% | $232,656 | 73.9K |
| 23 | EXPION360 INC | COM | 0.15% | $216,702 | 43.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2025 | $196M | 49 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $196M | 49 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $194M | 50 | Nov 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $168M | 48 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $172M | 47 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $149M | 44 | Jan 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $130M | 47 | Oct 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $145M | 47 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $135M | 47 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $138M | 47 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $112M | 41 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $118M | 41 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $135M | 41 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.